We would like to thank all participants for taking part in the International Conference „Clinical Genetics of Cancer 2022”.

We invite you to participate in the Scientific Conference next year.

Serdecznie dziękujemy wszystkim uczestnikom za wzięcie udziału w Międzynarodowej Konferencji „Genetyka Kliniczna Nowotworów 2022”

Zapraszamy Państwa do udziału w Konferencji Naukowej w przyszłym roku.

PROGRAM KONFERENCJI  “CLINICAL GENETICS OF CANCER 2022” 

Międzynarodowa Konferencji „Genetyka Kliniczna Nowotworów 2022” została dofinansowana ze środków Ministerstwa Edukacji i Nauki w ramach programu „Doskonała Nauka” (projekt nr DNK/SP/550146/20221).

ABSTRAKTY

Abstrakt 1 Scott Rodney – Desmoid tumours, familial adenomatous polyposis and sporadic infiltrative fibromatosis

 Abstrakt 2 Hemminki Kari – Understanding of germline genetic basis of familial cancer

Abstrakt 3 Forsti Asta – Genetic predisposition to colorectal cancer: Identification of novel cancer susceptibility genes

Abstrakt 4  Backman Ann-Sofie – Mesalamine for Colorectal Cancer Prevention Program in Lynch syndrome

Abstrakt 5  Elsakov Pavel – Screening and efficacy of sporadic and hereditary CRC detection in low incidence population

Abstrakt 6  Kuświk Magdalena – Recommendation for preventive adnexectomy in MLH1 and MSH2 mutation carriers

Abstrakt 7 Irmejs Arvids – A spectrum and frequency of CHEK2 variants in breast cancer in Latvia, initial results and literature review

Abstrakt 8 Kowalik Artur – The spectrum of mutations in BRCA1/2 detected by NGS in pancreatic cancer patients considered for treatment with PARP inhibitor

Abstrakt 9  Pławski Andrzej – Simple method of detection of the most common PALB2 and RECQL genes mutations

Abstrakt 10 Kilar Ewa – Characterization of liquid-biopsy based microRNA profiles of BRCA1/BRCA2 positive patients – a preliminary study

Abstrakt 11 Szwiec Marek – The Impact of Oophorectomy on Survival from Breast Cancer in Patients with CHEK2 Mutations

Abstrakt 12 Grzybowska Ewa – The modification of response to treatment by non coding 3’UTR polymorphic variants in breast cancer patients

Abstrakt 13 Nowakowska Dorota – PTEN-HTS – Genotype-phenotype correlations – a single institution’s experience

Abstrakt 14 Wojdacz Tomasz – Increasing significance of methylation biomarkers in clinical cancer management

Abstrakt 15 Ogrodniczak Alicja – Constitutional BRCA1 promoter methylation and risk of ovarian cancer

Abstrakt 16 Pietrzak Sandra – Role of trace elements in early detection of cancer

Abstrakt 17 Kluza Marek – An Assessment of Serum Selenium Concentration in Women with Ovarian Cancer

Abstrakt 18 Lubinski Jan 1 – Elements in cancer treatment

Abstrakt 19 Lubinski Jan 2 – SELINA – all cause mortality decreased by selenium blood level optimization

Abstrakt 20 Kałużewski Bogdan – Report on the implementation of Early Detection and Prevention Programs for Cancers in Families with High, Hereditary Risk of Disease – Module I and Module II – in the group of patients covered by diagnostics and genetic counselling

Abstrakt 21 Prusaczyk Artur – Wybrane aspekty organizacyjne opieki nad rodzinami wysokiego ryzyka

Abstrakt 22 Gronwald Jacek – Optimization of the genetic diagnostics algorithm in patients with ovarian cancer from south-eastern Poland

Abstrakt 23 Siołek Monika – CHEK2 mutations and the risk of papillary thyroid cancer

Abstrakt 24 Cieszyńska Monika – The genetic risk of thyroid cancer among breast cancer patients